Patents by Inventor Sign Erickson Varner

Sign Erickson Varner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Devices for intraocular drug delivery
    Patent number: 8096972
    Abstract: A therapeutic agent delivery device that is particularly suitable for delivery of a therapeutic agent to limited access regions, such as the posterior chamber of the eye and inner ear. Preferred devices of the invention are minimally invasive, refillable and may be easily fixed to the treatment area. Preferred delivery devices of the invention also include those that comprise a non-linear shaped body member housing one or more substances and a delivery mechanism for the sustained delivery of the one or more substances from the non-linear shaped body member to the patient.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: January 17, 2012
    Assignee: Johns Hopkins University
    Inventors: Sign Erickson Varner, Eugene Dejuan, Jr., Terry Shelley, Aaron Christopher Barnes, Mark Humayun
  • Devices for intraocular drug delivery
    Publication number: 20040133155
    Abstract: An therapeutic agent delivery device that can allows is particularly suitable for delivery of a therapeutic agent to limited access regions, such as the posterior chamber of the eye and inner ear. Preferred devices of the invention are minimally invasive, refillable and may be easily fixed to the treatment area. Preferred delivery devices of the invention also include those that comprise a non-linear shaped body member body housing one or more substances and a delivery mechanism for the sustained delivery of the one or more substances from the non-linear shaped body member to the patient.
    Type: Application
    Filed: December 19, 2003
    Publication date: July 8, 2004
    Inventors: Sign Erickson Varner, Eugene Dejuan, Terry Shelley, Aaron Christopher Barnes, Mark Humayun